Cell division, membrane rigidity, and strong adhesion to a rigid matrix are all promoted by myosin-II, and so multinucleated cells with distended membranes-typical of megakaryocytes (MKs)-seem predictable for low myosin activity in cells on soft matrices. Paradoxically, myosin mutations lead to defects in MKs and platelets. Here, reversible inhibition of myosin-II is sustained over several cell cycles to produce 3-to 10-fold increases in polyploid MK and a number of other cell types. Even brief inhibition generates highly distensible, proplatelet-like projections that fragment readily under shear, as seen in platelet generation from MKs in vivo. The effects are maximized with collagenous matrices that are soft and 2D, like the perivascular niches in marrow rather than 3D or rigid, like bone. Although multinucleation of other primary hematopoietic lineages helps to generalize a failure-to-fission mechanism, lineage-specific signaling with increased polyploidy proves possible and novel with phospho-regulation of myosin-II heavy chain. Labelfree mass spectrometry quantitation of the MK proteome uses a unique proportional peak fingerprint (ProPF) analysis to also show upregulation of the cytoskeletal and adhesion machinery critical to platelet function. Myosin-inhibited MKs generate more platelets in vitro and also in vivo from the marrows of xenografted mice, while agonist stimulation activates platelet spreading and integrin αIIbβ3. Myosin-II thus seems a central, matrix-regulated node for MK-poiesis and platelet generation. matrix elasticity | blebbistatin | proteomics | thrombocytopenia A ctomyosin forces drive a number of general cellular processes. Fission at the end of cytokinesis is one such process promoted by myosin-II with inhibition of nonmuscle myosin-II (NMM-II) in proliferating cells producing more binucleate and polyploid cells (1). Second, actomyosin forces help to establish an active cortical tension, which stiffens and stabilizes the plasma membrane (2). Inhibition of NMM-II thus tends to cause at least some adherent cell types to exhibit more filipodia-like membrane extensions and appear more dendritic (1). Finally, NMM-II contributes to adhesion as cells attach to ligand and then pull and sense elasticity of their microenvironment, impacting differentiation of both adult (2) and embryonic stem cells (3). These basic functions of myosin are also partially coupled. Membrane or cortical rigidity increases with matrix rigidity as cells apply more tension to adhesion complexes on stiff substrates, promoting focal adhesion growth (2). Cytokinesis is also modulated by cell adhesion (4) with nonspecific attachment overriding the polyploidization described originally for suspensions of myosin-II-null Dictyostelium amoeba (5). However, cells in tissues do not grow in suspension: contact and adhesion are unavoidable in vivo. In all of these contexts, megakaryocytes (MKs) are intriguing in that they are polyploid, they exhibit proplatelet extensions suggestive of a highly flexible membrane, and they adhere within a complex bone marrow microenvironment (Fig. 1A) . MKs also express abundant NMM IIA (MYH9) as do MK-generated platelets (6).
Cell division, membrane rigidity, and strong adhesion to a rigid matrix are all promoted by myosin-II, and so multinucleated cells with distended membranes-typical of megakaryocytes (MKs)-seem predictable for low myosin activity in cells on soft matrices. Paradoxically, myosin mutations lead to defects in MKs and platelets. Here, reversible inhibition of myosin-II is sustained over several cell cycles to produce 3-to 10-fold increases in polyploid MK and a number of other cell types. Even brief inhibition generates highly distensible, proplatelet-like projections that fragment readily under shear, as seen in platelet generation from MKs in vivo. The effects are maximized with collagenous matrices that are soft and 2D, like the perivascular niches in marrow rather than 3D or rigid, like bone. Although multinucleation of other primary hematopoietic lineages helps to generalize a failure-to-fission mechanism, lineage-specific signaling with increased polyploidy proves possible and novel with phospho-regulation of myosin-II heavy chain. Labelfree mass spectrometry quantitation of the MK proteome uses a unique proportional peak fingerprint (ProPF) analysis to also show upregulation of the cytoskeletal and adhesion machinery critical to platelet function. Myosin-inhibited MKs generate more platelets in vitro and also in vivo from the marrows of xenografted mice, while agonist stimulation activates platelet spreading and integrin αIIbβ3. Myosin-II thus seems a central, matrix-regulated node for MK-poiesis and platelet generation. matrix elasticity | blebbistatin | proteomics | thrombocytopenia A ctomyosin forces drive a number of general cellular processes. Fission at the end of cytokinesis is one such process promoted by myosin-II with inhibition of nonmuscle myosin-II (NMM-II) in proliferating cells producing more binucleate and polyploid cells (1) . Second, actomyosin forces help to establish an active cortical tension, which stiffens and stabilizes the plasma membrane (2) . Inhibition of NMM-II thus tends to cause at least some adherent cell types to exhibit more filipodia-like membrane extensions and appear more dendritic (1) . Finally, NMM-II contributes to adhesion as cells attach to ligand and then pull and sense elasticity of their microenvironment, impacting differentiation of both adult (2) and embryonic stem cells (3) . These basic functions of myosin are also partially coupled. Membrane or cortical rigidity increases with matrix rigidity as cells apply more tension to adhesion complexes on stiff substrates, promoting focal adhesion growth (2) . Cytokinesis is also modulated by cell adhesion (4) with nonspecific attachment overriding the polyploidization described originally for suspensions of myosin-II-null Dictyostelium amoeba (5) . However, cells in tissues do not grow in suspension: contact and adhesion are unavoidable in vivo. In all of these contexts, megakaryocytes (MKs) are intriguing in that they are polyploid, they exhibit proplatelet extensions suggestive of a highly flexible membrane, and they adhere within a complex bone marrow microenvironment (Fig. 1A) . MKs also express abundant NMM IIA (MYH9) as do MK-generated platelets (6) .
Differentiation to MKs in vivo starts with multipotent hematopoietic stem cells (HSCs) that are located at osteoblastic niches on rigid, high collagen bone (7) . As MKs mature, they replicate their DNA but do not divide, a process termed endomitosis, and they also migrate into the soft marrow space and into perivascular niches (8) . MKs do not transmigrate into blood, perhaps because their polyploid nuclei are too large and rigid, but they do extend tubular membrane projections, known as proplatelets, into blood, where shear flow fragments the extensions to generate circulating platelets (8) . In case of injury to a vessel wall or perhaps other activating signals, platelets adhere to the wall or to a multiplatelet thrombus and use actomyosin forces to contract the thrombus and form a tight seal on the wall. We hypothesized that sustained inhibition of NMM-IIA together with soft matrices would maximize both MK maturation and proplatelet generation, and we sought insight into possible pathways of molecular regulation. Quality platelets for transfusion-as needed for various interventions (radiation, surgery) and diseases (leukemia)-are also supply-limited (9) .
Human mutations in MYH9 cause May-Hegglin anomaly, with large platelets that are reduced in number as thrombocytopenia (10, 11) . In mouse, deletion of MYH9 in MKs also produces MayHegglin-like defects (12, 13) . Paradoxically, pharmacological inhibition of NMM-II ATPase by blebbistatin in mouse adult (13) and mouse embryonic (14) systems is reported to produce a two-to ∼threefold increase in proplatelet extensions but not affect MK ploidy or size, at least for the doses or times tested. Whether human MK-poiesis is regulated by myosin-II has remained unclear, but possible pathways include direct phosphorylation of NMM-II (i.e., heavy-chain regulation that decreases myosin activity in other cells) (15) . Rho-associated protein kinase can affect myosin-II and is known to increase MK ploidy by approximately twofold (14) . Here, NMM-IIA's role in MK maturation and subsequent platelet production is examined directly starting with human bone marrow (BM)-derived CD34 + cells cultured with just two cytokines to differentiate into MK progenitors followed by sustained reversible inhibition of myosin-II for 3 d (Fig. 1B) . cells and monkey-derived epithelial COS-1 cells (Fig. S1 A and B) . THP-1 cells express NMM-IIA primarily (15) , and lentiviralknockdown using shRNA also increases polyploidy (Fig. S1C) . COS-1 cells express NMM-IIB almost exclusively, and knockdown by siRNA transfection likewise increases polyploidy (Fig. S1D) . Polyploidy is therefore not a pharmacological artifact of blebbistatin.
To investigate the additional role of myosin in membrane integrity under shear, cells were subjected to micropipette aspiration with stepwise decreases in pressure using pipettes similar in diameter to human capillaries (∼3 μm). The cell and its membrane shear and flow into the micropipette, resembling, in shape, elongated proplatelets. After just 30 min of blebbistatin, cells are approximately fourfold more compliant ( Fig. 1D and Fig. S2A ), and 40% of treated cells also rapidly fragment to average sizes similar to those of large human platelets (3 to ∼4 μm). Platelets are now known to be generated by shearing of proplatelets (16) , and no fragmentation was observed in untreated cells. Projection lengths up to the point of divergent fragmentation vary from 10 to ∼20 μm, which is similar to in vivo fragmented proplatelet lengths of ∼14 μm (8) . Fragmentation stresses here correspond to effective membrane tensions of ∼1 mN/m, which is 10-fold lower than cell membrane lysis tensions (17) . Platelets not only maintain membrane integrity but also exhibit characteristic structures, such as cortical, coil-like microtubules (MTs), and so we also aspirated primary MKs and MEG01 cells (an MK-like line) after labeling with a very low and cell-viable dose of fluorescent-Taxol (10 nM) (18) . Even at a 1,000-fold higher dose of Taxol, proplatelets are known to extend (19) . In slow aspirations here, MT-coils could be visualized extending into the projection tips at ∼0.7 μm/min (Fig.   S2 ) and bundles of MTs appear more likely than individual MTs, all consistent previously reported rates and structures (19) . Although final structures are rate-and force-dependent as transition rates ∼ exp(force) (17) , the basic findings here indicate both nonlytic fragmentation under shear and MK polyploidization could be promoted in part by myosin inhibition, even with microtubule polymerization as reported (19) .
Soft Matrix with Low Collagen Maximizes MK Polyploidy. Cell interactions with extracellular matrix (ECM) are unavoidable in vivo, and such interactions are modulatory, as found originally with substrate-assisted cytokinesis of myosin-null Dictyostelium (5). Furthermore, it seems inevitable in BM (Fig. 1A) that migrating MKs encounter gradients in both tissue elasticity and collagen density (20) . The bone surface is high in collagen-I (collagen hi ) and stiff, with an estimated elasticity E ECM for osteoid of ∼34 kPa (2), whereas the marrow space is collagen lo and very soft, approximated here with E ECM = 0.3 kPa (21) . MKs express two collagen receptors: GPVI and integrin-α2β1 (22, 23) . Previous results indicate that collagen suppresses maturation of MKs in vitro (24) , and so we hypothesized that a low collagen, compliant ECM favors MK polyploidization. CD34 + cells were cultured on polyacrylamide gels of controlled stiffness with different collagen concentrations per previous studies with BM-derived mesenchymal stem cells (2) , which showed matrices as soft as muscle are myogenic, whereas matrices that are stiff like osteoid induce osteogenesis.
At low collagen (2 ng/cm 2 ) and on soft gels (0.3 kPa), polyploid MK increase (by 50%) compared with stiff gels (34 kPa), indicating roles of matrix elasticity in regulating polyploidy ( Fig. 2A ). This effect is maintained over a range of collagen concentrations (2-200 ng/cm 2 ) (Fig. 2B ), but is abolished by blebbistatin except for the lowest collagen (2 ng/cm 2 ). Above a matrix ligand threshold, cells can sense elasticity via myosin (plus other mechanisms, per Fig. 2A ). These processes are fully decoupled in suspension cultures (Fig. 1C) .
Because adhesion opposes polyploidy of myosin-null amoeba (4), we further tested-by a simple inversion of submerged cultures (1 g for 30 min)-whether increased adhesion could explain reduction in polyploid MK numbers on stiff gels. Although standard plastic-dish cultures under serum-free conditions show no attachment and are thus suspension cultures, 50% more cells remained anchored to stiff matrices versus soft matrices, with the greater adhesion depending on active NMM-II (Fig. 2C) . Nonetheless, adhesion to all collagenous gels with or without myosin inhibition was at least 20-fold higher than the near-zero attachment to plastic. Understandably, polyploidy increases (almost twofold) with increasing collagen concentration on stiff gels as cells anchor so strongly that they cannot migrate away to complete division (Fig.  2D ). Migration is well-known to be biphasic in adhesive ligand, with low ligand promoting migration but high ligand leading to immobilization. Matrix ligand density and stiffness therefore factor in as cells complete cytokinesis by crawling apart, even when myosin is ablated (5).
Soft 2D Collagenous Matrices Are Better than Stiff or 3D. For some cells but not all, NMM-II inhibition causes a dendritic morphology on rigid substrates (1) , and this is true of the COS-1 cell line too (Fig. S3 A-D) , which also stains positive with a dye for lipid "demarcation" membranes within polyploid MKs, even though some major differences are expected between lineages (Fig. S3E) (25) . The morphology effects are reminiscent of blebbistatin, causing an increased number of MKs with proplatelet extensions when cells are grown on plastic (13, 14) , and we indeed find an approximately threefold increase in mean length of proplatelet extensions under such conditions (Fig. 2E) . Live imaging shows the average proplatelet extension velocity is ∼1 μm/min, consistent with a previous study (16) (Fig. S3 F and G and Movie S1A).
Soft collagenous gels-in both 2D and 3D-facilitate proplatelet extensions compared with stiff gels (Fig. 2E ). Blebbistatin has a considerable additive effect only with 2D soft matrices, with the drug having no effect on cells in 3D collagen gels or on stiff, osteoid-like matrices. Perhaps the major difference between 2D soft and pure 3D matrix is the high density of ligand in 3D, and as with polyploidy, high collagen tends to anchor and suppress any effect of blebbistatin (Fig. 2D ).
Myosin-II Heavy Chain Is the Best Target for MK Maturation. For drug treatment times much shorter than the doubling time (∼18 h), cells continue to divide and a low number of polyploid MKs are generated. For longer treatment times, however, division is indeed inhibited and more polyploid MKs are generated (Fig. 3A) . Polyploid cell numbers grow exponentially with duration of drug exposure, and the doubling time for polyploidization proves consistent with drug-free cell proliferation. Other contractility inhibitors are much less effective (Fig. S4A ). In addition, stem-cell factor (SCF) and thrombopoietin (Tpo) favor MKs, but addition of G-CSF plus blebbistatin produces polyploid CD41 − cells (Fig.  S4 B and C) , and time-lapse imaging shows most cells reverse cytokinesis ( Fig. 3B and Movie S1B). Restriction of endomitosis to MKs thus suggests lineage-specific signaling to myosin.
Phospho-Regulation of NMM-IIA and Polyploidy. NMM-II is of course abundant in platelets as well as MKs (6), but phosphoregulation of myosin heavy chain remains a topic of active study. Phosphorylation of S1943 is downstream of EGF receptor, inactivates myosin in epithelial cells, and impacts cell motility (26) . PDGF is one known ligand of EGF receptor (27) and reportedly increases the number of MK progenitors (28) . Mass spectrometry (MS) analyses of primary cells revealed approximately eightfold more phospho-S1943 in MKs vs. non-MK (CD41 − ) cells (Fig. 4A and Dataset S1A), suggesting myosin inactivation accompanies MK differentiation. THP-1 cells immunoprecipitated with an antibody against NMM-IIA (Fig. S5) show blebbistatin increases phospho-S1943 when NMM-IIA is a detergent-soluble monomer rather than polymer ( Fig. S6A and Dataset S1B). This finding is consistent with pSer-deactivation of myosin through inhibition of polymerization (26) .
Phosphorylation of Y277 has been implicated in B-cell function (29) , and phosphorylation of both Y277 and Y1805 activates myosin for phagocytosis by macrophages (15) . Because inhibition or knockdown of NMM-IIA in THP-1 cells caused a major increase in polyploidy (Fig. S1A) , we examined pTyr in THP-1 and find that blebbistatin decreases pTyr levels under both basal and phosphatase-inhibited conditions. The difference is apparent in NMM-IIA's head plus proximal tail (a 150-kDa fragment) as characterized by immunoprecipitation (IP) (Fig. 4B) followed by detailed MS analysis (Fig. S5 ). Most tryptic peptides from the IP were from NMM-IIA (Dataset S1C). Myosin inhibition thus feeds back into signaling pathways.
Given the opposite roles of tyrosine (activating) and serine (deactivating) phosphorylation in modulating myosin activity, we studied which phospho-sites in NMM-IIA might regulate ploidy by taking advantage of the easily transfectable COS cell lines that were previously used to study roles of NMM-II isoforms in cytokinesis (see SI Materials and Methods). Because inhibition or knockdown of NMM-IIB in COS-1 cells increases polyploidy (Fig.  S1B) , NMM-IIA heavy chain phospho-mutants were expressed in native COS-1 and in the knockdowns (Fig. 4C) . The head mutant Y277F increases the number of polyploid cells by approximately twofold (Fig. S6B ), but phospho-mimetic mutant Y277D abolishes this effect. The pTyr mutant Y1805F in the tail also has no effect on ploidy, but the double mutant Y277F-Y1805F has the same effect on polyploidy as the head mutant. Knockdown of NMM-IIB with siRNA (Fig. S1D) shows the expected trends: polyploidy of GFP-transfection controls exceeds native levels, whereas wild-type NMM-IIA rescues partially with suppression of polyploidy. The Y277F mutant acts as a dominant negative (on residual NMM-IIB) and produces the highest levels of polyploidy, with 50% of cells showing ≥8 N. Overexpression of phospho-mimetic serine mutants of NMM-IIA, S1943D and -E, also prevents significant rescue of polyploidy, suggesting pS1943 functionally regulates myosin activity and ploidy. Visualization of the various GFP-NMM-IIA constructs shows the wild-type to be structured in cells, perhaps like stress fibers, but the Y277F mutant is far more diffuse (Fig. S6C) . The results thus identify at least two specific signaling targets in myosin heavy chain that can regulate polyploidization, thereby implicating upstream signaling pathways in the marrow's perivascular niches for MKs.
Proteomic Profile of Blebbistatin-Treated MKs Is Platelet-Like. Because blebbistatin promotes maturation of CD41 + cells in terms of ploidy and proplatelets, the proteomic profile of drug-treated cells might be expected to better approximate that of platelets, which have been extensively profiled (Dataset S1D). Using a unique label-free analysis of proteomes based on proportional peak fingerprints (ProPF) (see SI Materials and Methods) and motivated by the reported up-regulation in MKs of 22 actin cytoskeleton genes, five α-and β-tubulin isoforms, and just one down-regulated actin cytoskeletal gene (30), we quantified all cytoskeletal proteins for which three or more tryptic peptides were detected in four distinct cell lysates: CD41 − , CD41 + , drug-treated, and not drug-treated ( Fig. S7 A and B) . CD41
− cells include many hematopoietic cells that are CD34 hi , a marker of HSCs and progenitors of various lineages ( Fig. S7C and Dataset S1E). Normalization to untreated CD41 − cells shows blebbistatin has little effect, increasing expression modestly of only 20% of the indicated proteins (Fig. 5 ). In contrast, CD41
+ cells show considerable up-regulation: 50% of detected proteins in untreated samples and 75% in treated samples are up. This finding suggests an increasing level of differentiation especially in contractility with heavy and light myosin-II chains, and also adhesion linkers talin and vinculin (detected proteins in Dataset S1 E and F). Tubulin α-and β-isoforms are also slightly up and to a similar extent as expected of heterodimers. Validation of the proteomics with antibodies against key proteins, including NMM-IIA and vinculin (Fig. S7D ), proved consistent with mRNA up-regulation of NMM-IIA and vinculin in MKs (30) .
Reversible Inhibition of NMM-II Increases Functional Platelet Numbers.
Transplantation of uncultured human cord-blood CD34
+ cells in immuno-deficient nonobese diabetic (NOD)/SCID mice has been shown previously to yield sustained generation of human platelets (31) , but the intravenous delivery route used to date requires a large number of cells for homing and engraftment. Intrabone marrow transplantation was instead used here to more rapidly expose injected cells to the marrow microenvironment per Fig. 1A . Nucleated cellular fractions of CD34 + cells cultured with SCF and Tpo with or without blebbistatin were xenografted into NOD/ SCID/IL-2Rγ −/− (NSG) mice, and human MK were indeed detectable within the tibia and not lung or spleen at day 3 posttransplant (Fig. S8A ). Subsequent quantification of circulating human-CD41 + platelets at day 3 indicates that human cells treated ex vivo with blebbistatin generate more in vivo human platelets per transplanted CD41
+ cell by about fourfold (Fig. 6A , Left). These in vivo-generated platelets derive from CD41 + cells because CD34 + cells do not generate platelets until after 2 wk (31). To determine if the in vivo observations could be recapitulated in vitro, MKs exposed to blebbistatin for 3 d were washed and the nucleated cell fraction was isolated by a density gradient to remove any existing fragments (32), followed by further culture with Tpo The first column summarizes detectability in prior literature on platelets. <PRF> refers to the number of peptides retained in propotional peak fingerprint for protein quantitation, whereas "Total" refers to all peptides detected.
for 3 d. Counting the in vitro-generated, platelet-sized fragments indicates that blebbistatin-exposed MKs generate 2.5-fold more in vitro platelets per CD41 + cell than untreated MKs (Fig. 6A , Right). Human platelet-like fragments derived from both untreated and blebbistatin-exposed MKs show cortical, coil-like MT structures as seen in some human blood-derived platelets (Fig. 6B) . Furthermore, unlike platelets derived from patients with MayHegglin anomaly (33) , platelets derived from blebbistatinexposed MKs as well as MKs themselves do not exhibit reduced CD42b expression compared with untreated controls and blood platelets; the CD42b to CD41 mean fluorescent intensity ratio remains similar (Fig. S8B) . In vitro-generated platelets are not subjected to fluid shear and are expected to be larger, as seen in imaging ( Fig. 6C and Fig. S8C ), with higher CD41 and 42b intensities (Fig. S8B ) and higher forward scatter compared with blood platelets. Reversible but sustained NMM-II inhibition thus does not compromise MK and platelet structure or surface marker expression (Fig. 5 and Fig. S7D ).
Regardless of blebbistatin treatment, MK-derived platelets are capable of forming filopodia on collagen-I matrix upon thrombin stimulation (at 1 U/mL) (Fig. 6C) . F-actin also reorganizes through αIIbβ3 integrin outside-in signaling, as revealed by formation of filopodia, lamellipodia, and stress fibers on fibrinogen upon thrombin stimulation (at 1 U/mL) (Fig. S8C) . MKs themselves spread and form stress fibers on fibrinogen regardless of blebbistatin treatment (Fig. S8D) , as reported for murine ESC-derived MKs (34) . Furthermore, the active conformation and clustering of human αIIbβ3, which binds fibrinogen, was directly confirmed with PAC-1 antibody binding upon stimulation of platelet-like fragments derived from both untreated and blebbistatin-treated MKs (Fig. 6D) . Specificity of agonist-induced PAC-1 binding was verified by inhibiting αIIbβ3 activation with tirofiban (10 μM) per Takayama et al. (35) . Blebbistatin-exposed MK-derived in vitro platelets thus preserve major functional responses of blood-derived platelets. Additionally, human platelets obtained from NSG mouse transplants of MKs (Fig. 6A, Left) show activation by known agonists (ADP, PMA, and thrombin) of P-selectin expression (Fig. S8E) . Levels are similar to those reported for human platelets generated in NOD/SCID mice 2 wk after transplantation of CD34 + cells (31) . The results thus indicate that transient ex vivo inhibition of NMM-II by the protocol here increases the number of functional human platelets.
Discussion
Deletion of the one myosin-II gene in Dictyosteum causes multinucleation of cells in suspension, but division proceeds with cells on glass coverslips via traction-mediated motility (4). This finding is critical to understand more thoroughly because adhesive attachment in tissues, such as BM, is unavoidable (Fig. 1A) . Here, inhibition of NMM-IIA over several cell cycles invariably enhances polyploidization of primary human-MKs (Fig. 1C) , as well as G-CSF-induced CD34 + cells (Fig. S4 B and C) , COS-1s, and THP1s (Fig. S1 ). The effect on MKs is maximized when grown on marrow-mimetic soft matrices with low collagen density (Fig. 2) . Stiff or rigid, ligand-coated matrices are well known to strengthen adhesion by mechanisms that at least involve myosin-II-dependent growth of focal adhesions (2) . Soft matrices here nonetheless show adherent cell numbers are still ∼2,000% above nonspecific attachment to plastic, but adherent cell numbers on stiff matrices are only about 50% higher (Fig. 2C) , with blebbistatin suppressing the difference. Anchorage to stiff matrix is thus not only detectably stronger but stiff, collagen hi matrix even promotes polyploidy (∼twofold) relative to MK on plastic (Fig. 2D) , presumably through anchorage-limited motility. Blebbistatin is nonetheless more potent to cells on soft collagen lo matrix, which minimizes adhesion-facilitated motility, and thereby maximizes polyploidy.
Mouse ESC-derived MKs treated with blebbistatin (14) did not show higher polyploidy, probably because treatment duration was too brief relative to cell cycle (Fig. 3A) . In addition, drug doses of ∼100 μM are 20-fold above the K i (Fig. 1C) and in a range that we find to be toxic, indicative of off-target effects (see SI Materials and Methods). Lineage-specific NMM-IIA knockout mouse models also did not show increased polyploidy in previous studies (12) , probably because the knockout is irreversibly sustained; our 3-d treatment is long relative to cell cycle but not so long that offtarget effects accumulate and undermine cell viability. A physiological pathway of myosin-II deactivation (Fig. 4) conceivably involves transient signaling from lineage specific upstream factors, which remain to be identified. Y277 on the myosin-II head involves SHP-1/2 phosphatase (29) , and S1943 in the tail is downstream of growth factors (perhaps PDGF). The drug approach here mimics such niche signaling to maintain cell viability and even enhance myosin protein levels in MKs (Fig. 5) .
The activity of NMM-II typically contributes a cortical tension that stiffens and stabilizes the plasma membrane (2), and so inhibition of NMM-II understandably causes at least some adherent cell types to generate more filipodia-like extensions (1), as seen here also with COS-1 cells (Fig. S3 A-D) . In addition, with strongly adherent cells, NMM-II is activated into stress fibers on rigid matrices (2), and so a soft, collagen lo matrix would seem optimal to minimize adhesive activation of NMM-II. For these reasons, blebbistatin-treated MKs on the marrow-mimetic soft, collagen lo matrix are optimal for proplatelet extensions (Fig. 2E) . Micropipette aspiration indeed demonstrates that myosin inhibition allows fluid forces to extend and fragment cell membranes (Fig. 1D) , while aspiration also bends and distends microtubule loops (Fig.  S2 ). This finding is fully consistent with the emerging picture (Fig.  1A) that proplatelet extensions into blood flow permit shear fragmentation to generate circulating platelets (8) . A similar magnitude of softening with myosin inhibition was also documented with mesenchymal stem cells (2) as well as in natural MK maturation (36) .
MK maturation involves changes in the proteome (Fig. 5 ) that fit a remodeled, platelet-generating phenotype. Adhesion proteins up-regulated in CD41 + cells, with or without blebbistatin, include talin and vinculin, indicative of an adherent phenotype. Blebbistatin-treated CD41 + cells up-regulate NMM-IIA, myosin light chains, and also actin and tropomyosin which seems consistent with previous results showing myosin inhibition reduces actin turnover and leads to F-actin stabilization (37), contributing to membrane extensions. Microtubules also show a tendency to polymerize into such extensions, as seen in proplatelets (Fig. S2B and Fig. 3D ) (16) 
MKs exposed to blebbistatin for several days generate platelets with a morphology and activatable-functionality similar to those from untreated MKs and approximating blood platelets. Increased functional platelet number is therefore a result of NMM-II inhibition of MKs. The NMM-II inhibition here is reversible after drug washout (1) and, given the abundance of NMM-II in platelets (6), it seems more likely that the irreversible deficiencies or mutations of NMM-II in May-Hegglin anomaly will undermine platelet function, as observed clinically with macrothrombocytopenia and reduced surface platelet proteins, such as CD42b (33) . Results here thus implicate regulated NMM-II coupled to a soft marrowmimetic matrix in the polyploidization of MKs and in membrane softening with proplatelet extensions, ultimately amplifying platelet numbers in vivo.
Materials and Methods
Details of cell culture, micropipette analysis, construction of collagen-coated gels, and other techniques are in SI Materials and Methods. Cells from >10 different donors were used. Our unique label-free MS quantitation of protein (developed by J.S.) uses peptide ion currents from those peptides that maintain proportionality within and between samples. 2+ or Mg 2+ (Invitrogen) was supplemented with either 1% BSA or 2% FBS (Sigma-Aldrich). For cell culture, DMEM, RPMI-1640 medium, 0.05% trypsin-EDTA, penicillin-streptomycin were all purchased from Invitrogen. For Western analysis, protease inihibitor mixture was purchased from Sigma. For flow cytometry, 7-Amino-actinomycin D (7-AAD) was purchased from Sigma and Hoechst 33342 was purchased from Invitrogen. The (±)-blebbistatin was purchased from EMD Biosciences, and reversine, ML-7, and Y-27632 were purchased from Sigma. All cytokines, including human recombinant stem-cell factor (SCF), thrombopoietin (Tpo), and G-CSF, were purchased from R&D Systems. + cells were obtained from either the Penn Xenograft Core Facility or AllCells. Cells from at least 10 different donors were used in this study. Purity of the samples (>98%) was confirmed by flow cytometry with monoclonal antibody against human CD34 conjugated to phycoerythrin (PE). All experiments were performed in hematopoietic stem cell (HSC) expansion media (StemLine-II; Sigma) supplemented with 1× antibiotics, and the following human recombinant cytokines: SCF (100 ng/mL) and Tpo (100 ng/mL). In some occasions, the media was also supplemented by G-CSF (100 ng/mL). All cytokines were purchased from R&D Systems. After cells were cultured for 4 d, they were treated with different doses of cellular contractility inhibitors, including (±)-blebbistatin (EMD Biosciences), reversine, ML-7, and Y-27632 (Sigma) for indicated durations of up to 3 d. Unfortunately, longer exposure to drug proves toxic even to polyploidy cells under the present culture conditions. Cells were then resuspended in PBS/2% FBS medium and subjected to ploidy analysis: cells were stained with CD41-FITC (BD Biosciences) at room temperature for 30 min, followed by Hoechst 33342 at 37°C for 30 min. Then cells were stained with Annexin-V-PE (BD Biosciences) in the Annexin-V staining medium, followed by addition of 7-AAD. Stained cells were subjected to flow cytometric analysis (LSR-II; BD Biosciences): only viable cells (7-AAD − and Hoechst 33342 + ) were analyzed for ploidy. Cells with the DNA content of 8 N or higher were considered polyploid. To quantify absolute number of polyploid cells, viable cell number was counted before flow cytometry by Trypan blue exclusion, and this number was multiplied by percentages of each DNA compartment and subpopulations. Each multiplied number was then normalized by initial cell input number before drug treatment in culture.
Supporting Information
Plasmid Construction and RNA Nucleotides. The original construct that contains GFP-fused human NMM-IIA heavy-chain sequence with the cytomegalovirus promoter was described previously (1) and obtained from Addgene (GFP-NMM-IIA). Single and double point mutants Y277F and Y1805F were constructed previously by our laboratory (2) . A serine residue GFP-NMM-IIA point mutant S1943A was created by point-mutation, using the QuikChange II XL Site-Directed Mutagenesis Kit (Stratagene), according to the manufacturer's instructions, with the following primers:
5′-GCCGGGGATGGCGCCGACGAAGAGG-3′ (sense) 5′-CCTCTTCGTCGGCGCCATCCCCGGC-3′ (antisense) All mutant constructs were confirmed by sequencing. For NMM-IIB siRNA duplexes, the sequences were obtained from Bao et al. (3) and were synthesized by Dharmacon, Inc., along with scrambled siRNA.
Cell Culture, Transfection, and Ploidy Analysis in COS-1 Cells. COS-1 cells were obtained from ATCC and were maintained in highglucose DMEM with 10% FBS. Lipofectamene 2000 was used for both siRNA knockdown of NMM-IIB and overexpression of NMM-IIA constructs, according to the manufacturer's instructions (Invitrogen), when cells were 5% to 10% and 60% to 70% confluent, respectively. Efficiency of NMM-IIB siRNA was confirmed to be >90%, as indicated by quantitative immunofluorescence analysis (Fig. S1D) . For GFP-tagged NMM-IIA constructs, the transfection efficiency was about 30% to ∼40%. For overexpression studies without siRNA, cells were supplemented with fresh medium 24 h after transfection, followed by culturing for 3 more days before ploidy analysis. For rescue studies, NMM-IIB siRNA was transfected and cultured for 2 d, followed by transfection of GFP-tagged NMM-IIA constructs. The medium was changed to fresh and cells were cultured for 3 additional days before the analysis. Ploidy analysis of adherent COS-1 cells was done by detachment of cells in the presence of PBS/10 mM EDTA/5% FBS at 37°C for 5 min. After making a singlecell suspension with pipetting and filtering, cells were then labeled with Hoechst 33342 at 37°C for 30 min. Cells were chilled on ice and 7-AAD was added. Only 7-AAD − (viable) and GFP + (transfected) cells were analyzed for cellular ploidy.
In Vivo Transplantation Studies with Xenograft Models. Eight-to 10-wk-old nonobese diabetic (NOD)/SCID/IL-2Rγ −/− (NSG) mice were obtained and maintained in-house at the Penn Xenograft Core Facility. Before transplantation (∼24 h), mice received a sublethal dose of 320 cGy total body irradiation. Cultured human CD34
+ -derived cells (0.5-3 × 10 5 uncultured BM CD34 + equivalent) with or without drug treatment was suspended in 20 μL PBS and injected directly into the tibia. Peripheral blood (PB) was then obtained from the transplanted mice via retroorbital bleeding and human platelet quantification was done at indicated times. To calculate human platelet in NSG circulation, the total platelet concentration count was done by Hemavet (Drew Scientific), and 2 μL of PB per staining sample was washed in the presence of PGE1 inhibitor (Sigma) and resuspended in PBS. Cells were incubated with mouse Fc-blocker (BD Biosciences) for 5 min, followed by addition of mouse antihuman CD41-FITC and rat anti-mouse CD41-PE antibodies (eBioscience). After 30 min incubation at room temperature, cells were fixed by addition of 0.5% paraformaldehyde and analyzed by flow cytometry within 2 h. Platelets were gated on based on forward and side scatters, and at least 50,000 events were acquired. Human platelet concentration was obtained by multiplying the total platelet count by the percentage of human CD41-FITC of the total CD41 + platelets (mouse plus human). Microscopic determination and isotype control with mixing known number of human platelets indicate the threshold detection limit 0.001%. The total human platelet number in each transplanted NSG mouse was estimated by assuming that the average total mouse blood is ∼1.5 mL (4). All animal experiments were performed in accordance with institutional guidelines approved by the ethical committee from the University of Pennsylvania.
Functional Characterization of Megakaryocyte-Derived Platelets. Platelets derived from megakaryocytes (MKs) in culture or from xenograft blood were isolated by density gradient separation, as previously published (5) . For structural analysis of microtuble coils in platelets, platelet-sized isolate was fixed with 4% paraformaldehyde and immobilized on poly-D-lysine (100 μg/mL)-coated glass slides for 20 min, followed by permeabilization with 0.5% Triton-X in PBS. After samples were incubated with 1% BSA/PBS for 30 min to block nonspecific binding, cells were labeled with antihuman α-tubulin antibody overnight at 4°C, followed by secondary anti-mouse antibody (Alexa 488-conjguated) for 1 h at room temperature. A 60× oil lens was used to acquire images.
For platelet-spreading assays, platelet-sized isolate was resuspended in Tyrode's buffer supplemented with Mg 2+ and Ca 2+ , and adhered on fibrinogen (100 μg/mL) or collagen-I (200 μg/ mL)-coated glass slides for 45 min at 37°C in the presence of indicated agonists. After washing out nonadherent fragments cells three times with Tyrode's buffer, cells were fixed with 4% paraformaldehyde, followed by immunofluorescence staining with anti-human CD61 antibody and phalloidin (F-actin).
For platelet-activation assays, platelet-sided fraction isolated from either MK culture or NSG blood was resuspended in Tyrode's buffer supplemented with Mg 2+ and Ca 2+ , and incubated with indicated agonists for 15 min at 37°C, followed by staining with FITC-conjugated anti-human P-selectin or PAC-1 antibody (BD Bioscience), APC-conjugated anti-human CD41, and in the case of xenograft samples, PE-conjugated anti-mouse CD41 for 15 min at room temperature, followed by fixation with 1.5% paraformaldehyde. Antibody-stained samples were then analyzed by flow cytometry.
Platelet number was evaluated by mixing each sample with a defined number (∼10,000 beads per sample) of APC-conjugated beads (BD Bioscience). The number of platelets per sample was evaluated by: number of CD41 + events/number of APC-bead events × total known number of APC-bead added per sample.
Micropipette Aspiration. Cells from BM CD34 + cultures in SCF and Tpo between 3 and 8 d were treated with 20 uM blebbistatin for 30 min to 1 h, followed by micropipette analysis. Capillary tubes of 1.0-mm inner diameter (World Precision Instruments) were pulled into micropipettes using a Flaming-Brown Micropipette Puller (Sutter Instrument) and cut further using a deFonbrune-type microforge (Vibratome). The average micropipette diameter was around 3 μm. Micropipettes were attached to a dual-stage water manometer with reservoirs of adjustable height. Suction was applied by a syringe, and the corresponding pressure was measured by pressure transducer (Validyne) calibrated by a mercury U-tube manometer. Pressures for different experiments ranged from 0.5 to 20 kPa. In some cases, cells were labeled with a very low dose (10 nM) of fluorescent BODIPY-Taxol (Invitrogen) for 1 h at 37°C to visualize the initial stage of microtubule polymerization during micropipette aspiration.
Construction of Collagen-Coated Gels with Different Matrix Elasticity.
Fifteen-to ∼18-mm glass coverslips were treated in order with ethanol, RCA solution (1:1:3 for 15N NH 4 OH:30% H 2 O 2 :dH 2 O), methylene chloride, and 0.1% allyltrichlorosilane solution. To control the gel's stiffness, N,N′methylene-bis-acrylamide and the acrylamide solution was mixed at the ratio of 0.07%:3% for soft gels (0.3 kPa), or the ratio of 0.3%:8% for stiff gels (34 kPa), final concentrations in PBS. Approximately 25 μL of the mixed solution was polymerized on a coverslip with 10% ammonium persulfate and N,N,N′,N′-tetramethylethylenediamine. During polymerization, gels were covered with another coverslip to obtain a uniform gel surface with the final thickness of ∼100 μm. Different concentrations of collagen-I were then cross-linked with polymerized gels using sulfo-SANFAH (Pierce) by UV-crosslinking. Thickness of gels and relative collagen concentrations were verified by confocal microscopy; we assume that most collagen from the solution was attached to gels (>70%). Collagen-coated gels were then treated with UV in PBS for at least 1 h before use in cell culture.
Preparation of Collagen Matrix Cultures. Three-dimensional collagen gels embedded with cells were prepared as previously published (6) . BM-derived cells were added to the collagen solution prepared by neutralizing 2.0 mg/mL collagen-I (BD Biosciences) with HSC expansion media adjusted to appropriate the pH, so that cells could be embedded to the polymerized matrices (1 × 10 5 cells/mL). Next, 200 μL of this collagen mixture was placed in a well of 24-well plate and incubated at 37°C 5% CO 2 overnight before being formaldehyde-fixed and processed for microscopic analysis. Washing steps were done gently using pipette to minimize disturbance of gels. After completion of staining, matrices were released from the plate by gentle shaking and transferred to glass slides in mounting medium with either a spatula or gentle pipetting.
Adhesion Assay. BM CD34 + -derived cells were cultured on collagen gel coverslips for 3 d. Each well was filled gently with PBS and the coverslip from each well was immobilized. The plate was then immersed in a bath filled with PBS and inverted for 30 min to detach nonadherent cells at 1 g. After cell detachment, the plate was recovered and each coverslip was immediately fixed with 4% paraformaldehyde, followed by staining with F-actin and Hoechst 33342. Viable adherent cells were counted by looking at intact nuclear morphology and positive F-actin staining. The total cell number per well at day 3 culture before inversion was estimated from a separate culture plate that was prepared in parallel: all cells were detached by 10 mM EDTA/5% FBS solution for 5 min at 37°C and cells were counted by hemocytometer. The total adherent cell number was divided by the total cell number to estimate the percentage of adherent cells.
Immunoprecipitation and Western Blotting. In general, cells were washed with ice-cold PBS and lysed on ice with lysis buffer (150 mM sodium chloride, 1% Nonidet P-40, 1% protease inhibitor mixture, 1 mM activated sodium orthovanadate, 50 mM Tris at pH 8.0) for 30 min. For IP, 30 mM of pervanadate solution was prepared by mixing sodium orthovanadate with H 2 O 2 for 15 min at room temperature. At least 1 × 10 7 THP-1 cells were treated with pervanadate with or without blebbistatin at 37°C for 15 min. Cells were then washed, lysed, and whole-cleared lysate was mixed with anti-NMM-IIA antibody at 4°C overnight, followed by incubation with Protein G (Invitrogen) for 1 h. For Western blot, whole lysate or IP proteins were separated on 4% to 12% SDS/PAGE gels (NuPAGE 4-12% Bis-Tris, Invitrogen). The proteins were then transferred to a polyvinylidene fluoride (PVDF) membrane with an iBlot Gel Transfer Device (Invitrogen), followed by blocking with 5% nonfat dry milk solution for 1 h. Incubation with primary antibodies was done at 4°C overnight with 1:1,000 β -actin, 1:250 pTyr, and 1:1,000 NMM-IIA antibodies. After washing, the membrane was incubated with 1:2,500 anti-rabbit and 1:1,000 anti-mouse HRP-conjugated IgG antibodies at room temperature for 1 h. The blot was developed with ChromoSensor (GenScript) for 5 min, followed by digital scanning to perform densitometry analysis by ImageJ (National Institutes of Health).
Live Cell Imaging Analysis. At least 20,000 BM CD34 + -derived cells were put into Ibidi μ-slide VI (Ibidi GmbH) in cell culture medium. Analysis was done in an insulated chamber maintained at 37°C, 5% CO 2 . A series of images were collected every 5 min for 18 to ∼24 h with an Olympus IX70 inverted microscope with 300 W Xenon lamp illumination using 10× or 20× objectives under bright field. Image stacks were further analyzed by ImageJ to analyze cell division with or without blebbistatin treatment.
Immunofluorescence Analysis and Quantification. Cells on coverslips were fixed with 4% paraformaldehyde, followed by permeabilization with 0.5% Triton X-100 in PBS for 15 min and blocking with 1% BSA in PBS for 30 min. Samples were then stained with primary antibodies (1:100 for all antibodies used) overnight at 4°C. After washing, staining with appropriate Alexa-conjugated secondary antibodies (1:400) was performed for 45 min at room temperature. Cells were washed three times with PBS and mounted in ProLong Gold antifade medium (Invitrogen). Samples were then analyzed by fluorescence microscopy. For quantitative analysis, pictures from each experiment were taken under a defined set of exposure times on the same day with 40× objectives. Intensity of labeled NMM-II proteins for each cell was analyzed by ImageJ by subtracting a background, defining a threshold of cell boundary, followed by calculation of mean intensity. At least 10 images from each experiment were analyzed from three independent experiments. For proplatelet quantification, the process length from each cell was measured by manual tracing with ImageJ. Only processes above detection limit (≥ 1 μm in length from cell body) were considered for statistical analysis.
Visualization of Lipid "Demarcation" Membrane. Lipid "demarcation" membrane of MKs and COS cells was visualized as described previously (7). Briefly, cells stained with Hoechst 33342 were resuspended in PBS with 20 μM of a reversible styryl dye, FM 2-10 (Invitrogen). Cells were stained with the dye at room temperature for at least 20 min before visualization under fluorescent microscope with 488-nm excitation length. The images were obtained within 1 h of staining, as prolonged staining leads to penetration of the dye into the cytoplasm.
Cell Sorting. BM CD34 + -derived cells at day 7 were stained with CD41-FITC at room temperature for 1 h, followed by with Annexin-V-PE (BD Biosciences) in the Annexin-V staining medium for 15 min. Cells were then resuspended in 2% FBS/PBS with 7-AAD. Viable HSC-containing cell populations and differentiated MK lineages at day 7 culture were separated on the basis of CD41 surface expression by cell sorting performed on a FACS Vantage machine (Becton Dickinson). Dead cells stained with 7-AAD and Annexin-V were excluded from sorting. Sorted cells were directly processed for mass spectrometry (MS) analyses (Fig. 5) . 
The gel sections were dried by lyophilization before in-gel trypsinization [20 μg/mL sequencing grade modified trypsin in buffer as described in the manufacturer's protocol (Promega Corp.), 18 h at 37°C with gentle shaking). Before analysis, peptide solutions were acidified by addition of 50% digest dilution buffer (60 mM AM solution with 3% methanoic acid).
Peptide separations (5-μL injection volume) were performed on 15-cm analytical columns (75-μm inner diameter) packed with 5-μm C18 beads using a nanoflow high-pressure liquid chromatography system (Eksigent Technologies), which was coupled online to a hybrid LTQ-Orbitrap mass spectrometer (Thermo Fisher Scientific) via a nanoelectrospray ion source. The LTQOrbitrap was operated in the data-dependent mode to automatically switch between full-scan MS (m/z = 350-2000 in the orbitrap analyzer, with resolution of 60,000 at m/z 400) and the fragmentation of the six most-intense ions by collision-induced dissociation in the ion trap mass analyzer.
Raw MS data were processed using Elucidator (version 3.3, Rosetta Biosoftware). The software was set up to align peaks in data from samples derived from the same ranges of molecular weight. Peptide and protein annotations were made using SEQUEST (Thermo Fisher Scientific) with full tryptic digestion and up to two missed cleavage sites. Peptide masses were selected between 800 and 4,500 amu, with peptide mass tolerance of 1.1 amu and fragment ion mass tolerance of 1.0 amu. Peptides were searched against a database compiled from UniRef100 human, plus contaminants and a reverse-decoy database. Search results were selected with a deltaCn filter of 0.05 and mass error better than 10 ppm. Data attained from different slices of the same gel lane was combined by summing ion currents on a peptide-by-peptide basis based upon the peptide sequence annotation. Ion currents of oxidized peptides were summed with their parent peptide. When considering a total ion current, only signals from annotated peptides were summed. Label-free relative peptide quantitation was performed on proportional peak fingerprints (ProPF) of proteins with in-house software coded (by J.S.) in Mathematica (Wolfram Research). Datasets were normalized against optimized peptide sets that were found to be invariant between experimental conditions. Proteomes from primary MKs were analyzed using this unique method and a selected group of proteins were validated by antibodies (Fig.  S7D) . COS cells transfected with GFP-NMM-IIA and siRNA NMM-IIB knockdown were also analyzed by the method, and show increased NMM-IIA expression by 17-fold and partial knockdown (∼40%) of NMM-IIA compared with cells transfected with GFP and scrambled siRNA. There was minimal perturbation to other proteins detected. The analysis of two different cell types indicates that our label-free method is capable of quantifying protein levels in a reliable manner.
Statistical Analyses. All statistical analyses were performed using GraphPad Prism 4. Unless otherwise noted, all statistical comparisons were made by unpaired two-tailed Student t test and were considered significant if P < 0.05. All dose-response data were fitted to sigmoidal dose-response with variable slope with the x axis in a log scale. No MK were identified in other organs. (B) Evaluation of human CD41 and CD42b surface expression in MKs and MK-derived platelets by mean fluorescence intensity using specific antibodies and flow cytometry. Results from n = 3 donors (± SEM) with paired t test for untreated vs. bleb-exposed MKs (Upper); and for in vitro untreated or blebbistatin-exposed MK generated vs. blood platelets (Lower) (*P < 0.05). CD42b-to-CD41 ratio is also plotted for both MKs and platelets (P = not significant, ns). (C) In vitro platelets from blebbistatin-exposed MKs show normal adhesion, spreading, stress fibers, lamellipodia, and filopodia on fibrinogen upon thrombin (1 U/mL) stimulation. Rhodamine-phalloidin stains F-actin but antihuman-CD61 is used to confirm platelets (from n = 3 donors).
(Scale bars, 5 μm.) (D) Polyploid MKs exposed to blebbistatin show normal adhesion and stress fiber and lamellipodia formation on fibrinogen upon thrombin stimulation. Representative images from n = 3 donors are shown. (Scale bar, 10 μm.) (E) Evaluation of activation with human P-selectin (CD62P) expression on in vivo-derived human CD41 + platelet-like particles after MK transplantation into NSG mice. P-selectin is also known as platelet activation-dependent granule to external membrane protein. Platelets were isolated from transplanted NSC mice, and activated by 20 μM ADP, 1 μM PMA, or in combination with 20 U/mL thrombin plus Mg 2+ and Ca 2+ . Human P-selectin level after agonist stimulation was specifically evaluated by flow cytometry using specific antibodies against human CD41-APC, human P-selectin-FITC, and mouse CD41-PE. Only human CD41 + fraction from xenograft blood samples was analyzed for human P-selectin expression (n = 3 donors). One-way ANOVA P < 0.0005 and significant P values are reported from Tukey's HSD test: P < 0.05 for all pair-wise test between resting versus stimulated conditions of untreated MK-platelet, bleb-exposed MK-platelet, and blood platelet (n = 3 donors for each of MK-derived platelets and blood platelets) [Some data from Salles et al. (1) .] Dataset S1. Full datasets from quantitative proteomics analyses Dataset S1
When searching mass spectrometry (MS) datasets, the SEQUEST database was modified to include posttranslationally modified peptides. In addition to searching for alkylated cysteine residues (monoisotopic mass change, Δ = +57.021 Da; proteins are reacted with iodoacetamide before trypsin digestion) and oxidized methionine (Δ = +15.995 Da; peptides may be oxidized during sample processing and sample ionization), we searched for acetylation of lysine (Δ = + 42.011 Da), methylation of lysine and arginine (Δ = + 14.016 Da) and phosphorylation of serine, tyrosine, threonine, histidine, and aspartate (Δ = + 79.966 Da). (A) Posttranslational modifications (PTMs) to peptides derived from myosin IIa in the two MS analyses of sorted and treated cells (CD41 + and CD41 − , blebbistatin-treated and untreated; see Fig. 5 ). The extent of detection of the modified peptides was normalized against the total ion current of all myosin IIaderived peptides, and like Fig. 5 , they are expressed as ratios to the untreated, CD41
− sample. (B) PTMs to NMM-IIA derived peptides detected in the immunoprecipitation samples by mass spectroscopy. The SEQUEST database search was modified to look for posttranslationally modified peptides. It is routine to search for alkylated cysteine residues (monoisotopic mass change, Δ = +57.021 Da) because proteins are reacted with iodoacetamide before trypsin digestion and oxidized methionine (Δ = +15.995 Da), because of oxidation during sample processing and sample ionization. As these modifications were the product of sample handling, they were combined with the unmodified forms of the peptides by summing the integrated ion current. In addition to these modifications, we searched for acetylation of lysine (Δ = + 42.011 Da), methylation of lysine and arginine (D = + 14.016 Da), and phosphorylation of serine, tyrosine, threonine, histidine, and aspartate (Δ = + 79.966 Da). The table lists ratios between the ion currents of peptides containing the modified residues in blebbistatin-treated and untreated samples. (C) The proteins detected in each of the eight gel slices of the NMM-IIA immunoprecipitation experiment (Fig.  S8A) . To minimize the inclusion of incorrectly identified proteins, the analysis only considers proteins detected with two-or-more peptides derivative of the same protein identifying code (ID). Because of common protein sequences, many peptides are associated with multiple IDs and so a "primary ID" is selected that gives the greatest number of peptide-to-ID matches. In some cases (e.g., Q3MNF1), the number of peptides associated with a primary ID is low, but sequence coverage is high because a large number of additional peptides are common with another, more widely detected protein (see columns D, E, and F).
As all of the analyzed bands were found to contain principally the same components, the LC-MS elution profiles were aligned to allow quantitative comparison between samples. Columns G through N show the percentage of the total ion current for each of the proteins present. Although myosin-9 is the dominant protein detected, we also find noncovalently associated proteins (e.g., myosin light chains) that are also enriched by the IP. (D) This part lists the structural proteins detected by mass spectroscopy in the analysis of hematopoietic stem cells (HSCs) (both CD41 + and CD41 − , blebbistatin-treated and untreated; see Fig.  5 ). To minimize the probability of false-positive identification, all proteins listed were detected with three-or-more tryptic peptides per parent protein. The MS experiment was repeated three times, twice using a standard "in-gel" digestion process (experiments L132 and L206) and once using a "gel-free" digestion process (experiment L212, used for quantitative analysis; see 
